Fucoidan [9072-19-9]

Référence orb1299723-1g

Conditionnement : 1g

Marque : Biorbyt

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Fucoidan

SKU: orb1299723

Description

Fucoidan

Research Area

Metabolism Research

Images & Validation

Key Properties

CAS Number9072-19-9
MW256.27
Purity≥98% (May vary between batches)
FormulaC8H16O7S
SMILESCO[C@@H]1[C@@H](C)O[C@@H](C)[C@@H](OS(O)(=O)=O)[C@H]1O
TargetOthers,Glucosidase,glycosidase
SolubilityH2O:10 mM;DMSO:Insoluble

Bioactivity

In Vivo
Intraperitoneal injection of fucoidan in breast cancer models reduced the tumor volume and weight. The enhanced antitumor efficacy was associated with decreased angiogenesis and increased induction of apoptosis.
In Vitro
Fucoidan significantly decreased viable cell number in a dose-response manner with an IC50 of 550 ±4.3 μg/mL. Cell morphology was altered and significant apoptosis was induced when cells were exposed to 550 μg/mL fucoidan for 48 h.
Cell Research
The influence of fucoidan on B16 melanoma cells and cellular tyrosinase:Cell viability was examined by the cell counting kit-8 assay. Cellular tyrosinase activity and melanin content were determined using spectrophotometric methods and protein expression was analyzed by immunoblotting. Morphological changes in B16 melanoma cells were examined by phase contrast microscopy and apoptosis was analyzed by flow cytometry.
Animal Research
In vivo, therapy experiments were conducted on Babl/c mice bearing breast cancer. The tumor volume and weight were measured. The number of apoptotic cells and microvascular density (MVD) in tumor tissues were assessed by TUNEL and CD34 immunostaining. Immunohistochemical assays and ELISA assay were used to detect the expression of VEGF in tissues.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

anticancer, anticoagulant, antisteatotic, diabetes, Fucoidan, Glucosidase, Inhibitor, inhibit, polysaccharide, Type 2, α-amylase, α-glucosidase. Antioxidant
  • Antiviral Agent 51 [orb2564197]

    2165969-58-2

    242.25

    C7H14O7S

    50 mg, 10 mg, 25 mg, 5 mg, 1 mg, 100 mg

Key Properties

No computed properties available.

Protocol Information